Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pierre Rudolph

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Anticancer Research|December 12, 2003
Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapyChristiane Kuropkat, Pierre Rudolph, Reza Parwaresch, et al.
The Lancet. Oncology|June 18, 2002
Culprit and victim -- DNA topoisomerase IIUdo Kellner, Maxwell Sehested, Peter B Jensen, et al.
Oncogene|January 16, 2004
Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosisMatthias Krams, Reza Parwaresch, Bence Sipos, et al.
Cancer|February 22, 2002
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplificationMatthias Krams, Barbara Hero, Frank Berthold, et al.
The American Journal of Pathology|February 25, 2003
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastomaMatthias Krams, Barbara Hero, Frank Berthold, et al.
Anticancer Research|May 6, 2009
Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinomaChristian Cordes, Ann-Kristin Münzel, Pierre Rudolph, et al.
The Journal of Pathology|March 14, 2003
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancerHeidi Kühling, Per Alm, Håkan Olsson, et al.
International Journal of Cancer|May 13, 2003
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancerPierre Rudolph, Heidi Kühling, Per Alm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Repp86 expression and outcome in patients with neuroblastomaMatthias Krams, Hans-Juergen Heidebrecht, Barbara Hero, et al.
Clinical Chemistry|July 16, 2005
Separation of beta2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluidsTibor Görögh, Pierre Rudolph, Jens Eduard Meyer, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Anticancer Research|December 12, 2003
Ki-S1--a prognostic marker for hypopharyngeal carcinoma with potential predictive value for response to chemotherapyChristiane Kuropkat, Pierre Rudolph, Reza Parwaresch, et al.
The Lancet. Oncology|June 18, 2002
Culprit and victim -- DNA topoisomerase IIUdo Kellner, Maxwell Sehested, Peter B Jensen, et al.
Oncogene|January 16, 2004
Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosisMatthias Krams, Reza Parwaresch, Bence Sipos, et al.
Cancer|February 22, 2002
Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplificationMatthias Krams, Barbara Hero, Frank Berthold, et al.
The American Journal of Pathology|February 25, 2003
Full-length telomerase reverse transcriptase messenger RNA is an independent prognostic factor in neuroblastomaMatthias Krams, Barbara Hero, Frank Berthold, et al.
Anticancer Research|May 6, 2009
Immunohistochemical staining of Ki-67 using the monoclonal antibody Ki-s11 is a prognostic indicator for laryngeal squamous cell carcinomaChristian Cordes, Ann-Kristin Münzel, Pierre Rudolph, et al.
The Journal of Pathology|March 14, 2003
Expression of cyclins E, A, and B, and prognosis in lymph node-negative breast cancerHeidi Kühling, Per Alm, Håkan Olsson, et al.
International Journal of Cancer|May 13, 2003
Differential prognostic impact of the cyclins E and B in premenopausal and postmenopausal women with lymph node-negative breast cancerPierre Rudolph, Heidi Kühling, Per Alm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2003
Repp86 expression and outcome in patients with neuroblastomaMatthias Krams, Hans-Juergen Heidebrecht, Barbara Hero, et al.
Clinical Chemistry|July 16, 2005
Separation of beta2-transferrin by denaturing gel electrophoresis to detect cerebrospinal fluid in ear and nasal fluidsTibor Görögh, Pierre Rudolph, Jens Eduard Meyer, et al.
Pageof 2